Evidence map›Paper›PMID 41025068›Full record

ReviewWorld journal of gastroenterology2025

Gastroenterology in the age of artificial intelligence: Bridging technology and clinical practice.

Yagna Mehta, Saumya Mehta, Vishwa Bhayani, Sankalp Parikh, Rajiv Mehta

Abstract readReview
In one paragraph

Review in World journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yagna MehtaDepartment of Chemical Engineering, Nirma University, Ahemdabad 382481, Gujarat, India.
Saumya MehtaCarnegie Learning, Pittsburgh, PA 15219, United States.
Vishwa BhayaniUniversity of Missouri, Columbia, MO 65211, United States.
Sankalp ParikhDepartment of Gastroenterology, SIDS Hospital and Research Centre, Surat 395002, Gujarat, India.
Rajiv MehtaDepartment of Gastroenterology, SIDS Hospital and Research Centre, Surat 395002, Gujarat, India. rajivmehta@sidshospital.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The integration of artificial intelligence (AI), deep learning (DL), and radiomics is rapidly reshaping gastroenterology and hepatology. Advanced computational models including convolutional neural networks, recurrent neural networks, transformers, artificial neural networks, and support vector machines are revolutionizing both clinical practice and biomedical research. This review explores the broad applications of AI in managing patient data, developing disease-specific algorithms, and performing literature mining. In drug discovery, AI-driven computational chemistry is significantly speeding up drug discovery and development by accelerating hit identification, lead optimization, and formulation development. Machine learning models enable the precise prediction of molecular interactions and drug-target binding, thereby improving screening efficiency and reducing reliance on conventional experimental methods. AI also plays a central role in structure-based drug design, molecular docking, and absorption, distribution, metabolism, excretion, and toxicity simulations, while facilitating excipient selection and optimizing formulation stability and bioavailability. In clinical endoscopy, DL-enhanced computer vision is advancing ambient intelligence by enabling real-time image interpretation and procedural guidance. AI-based predictive analytics further support personalized medicine by forecasting treatment response in inflammatory bowel disease. Remote monitoring systems powered by AI are proving vital in managing high-risk populations, including patients with acute-on-chronic liver failure, liver transplant recipients, and individuals with cirrhosis requiring individualized diuretic titration. Despite its promise, AI potential in gastroenterology faces challenges stemming from data inconsistencies, ethical concerns, algorithmic biases, and data privacy issues including health insurance portability and accountability act and general data protection regulation compliance. Establishing standardized protocols for data collection, labeling, and sharing, alongside robust multicenter databases and regulatory oversight, are essential for ensuring safe, ethical, and effective AI integration into clinical workflows.

Indexed as

Artificial IntelligenceGastroenterologyDeep LearningDrug DiscoveryHumansNeural Networks, ComputerPrecision MedicineArtificial intelligenceDrug discoveryEndoscopyGastroenterologyPersonalized medicinePredictive analyticsRemote monitoring

Identifiers

PMID41025068
PMCPMC12476661

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.